Trace Amine-Associated Receptor 1 (TAAR1) agonists in a chemogenetic/molecular imaging model of increased dopamine synthesis capacity (Ki)

Project Information

TACtIK

Grant agreement ID: 101026235

DOI 10.3030/101026235

Project closed

EC signature date 9 March 2021

Start date 1 September 2021

End date 31 August 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 212 933,76

EU contribution € 212 933,76

Coordinated by

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom

Publications

Peer reviewed articles (2)

Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders

Author(s): Els F Halff, Grazia Rutigliano, Anna Garcia-Hidalgo, Oliver D Howes
Published in: Trends Neurosci, Issue 2023 Jan;46(1), 2023, Page(s) 60-74, ISSN 0166-2236
Publisher: Elsevier BV
DOI: 10.1016/j.tins.2022.10.010

Therapeutic potential of taar1 agonists in schizophrenia: Evidence from preclinical models and clinical studies

Author(s): Nina Dedic, Heather Dworak, Courtney Zeni, Grazia Rutigliano, and Oliver D. Howes
Published in: International Journal of Molecular Sciences, Issue Volume 22, Issue 24, December-2 2021 Article number 13185, 2021, ISSN 1661-6596
Publisher: MDPI
DOI: 10.3390/ijms222413185